Compassionate Care for Patients with
disease is a degenerative brain disorder that impacts the way the brain stores
and retrieves memories. Four percent of people have the disease at age 75, but
by age 85, the average climbs to 50 percent – and even higher if there is a
no cure for Alzheimer’s, but specialized treatments can improve the outlook for
patients suffering from this disorder and other types of dementia or memory
Southwestern is at the forefront of Alzheimer’s disease research. Our
Alzheimer’s Disease Center is one of only 29 institutions nationwide funded by
the National Institute on Aging to evaluate patients and conduct scientific
research on the causes of Alzheimer's disease. In addition, UT
Southwestern’s Center for
Alzheimer’s and Neurodegenerative Diseases, led by Marc Diamond, M.D., uses a multidisciplinary
approach to speed the development of effective treatment for neurodegenerative
staff includes neurologists who specialize in behavioral neurology and
neuropsychiatry, an advanced practice professional (APP), a neuropsychologist,
and a psychometrist.
at UT Southwestern receive thorough diagnostic evaluations to identify and
classify any existing cognitive or memory problems or disorders.
the most advanced diagnostics to provide a roadmap for treatment. Tests we
Caring for Patients and Their
works to provide patients and their caregivers with the latest in medical
therapy, nutrition, and ongoing brain scans and monitoring of symptoms to help
patients and their families make decisions about upcoming health care and lifestyle
concerns, such as when to stop driving and when to consider full-time care.
Alzheimer’s Disease Center holds a monthly caregiver support group to help the
families of our patients, as well as numerous outreach activities such as
community seminars and conferences relating to brain health, Alzheimer’s
disease, and research.
Research and Clinical Trials
research at UT Southwestern has made important strides in understanding
diseases of memory and cognition, and it provides new hope for future
our patients and their families to be part of that progress by participating in
clinical trials at UT Southwestern’s Alzheimer’s Disease